Lung Cancer Patients Need More Help In Making Treatment Choices

September 18, 1998

(Preferences for chemotherapy in patients with advanced non-small cell lung cancer: descriptive study based on scripted interviews)

Little is known about how lung cancer patients value the potential benefits and risks of chemotherapy. In this week's BMJ Professor Gerard Silvestri from the Medical University of South Carolina and colleagues report that some patients with lung cancer may not be getting the treatment they would choose if they were fully informed.

In their survey of 81 patients who had received chemotherapy treatment, several people said that they would choose chemotherapy if it would increase their survival by as little as a week, whereas others say they would not choose this option, even if it meant they would live for another two years. The majority of those interviewed claimed that if undergoing chemotherapy would prolong their life by three months, they would only take this option if it could improve their quality of life for this period. Most patients would want considerably more time than chemotherapy could currently provide.

Patients previously treated with chemotherapy vary considerably in their attitudes towards this highly toxic treatment and the authors conclude that choosing the proper treatment for cancer patients requires that they are fully aware of the merits of chemotherapy. Their results suggest that currently some patients may not be getting what they want.

Contact: Gerard Silvestri, Associate Professor of Medicine, Medical University of South Carolina, Charleston USA


Related Lung Cancer Articles from Brightsurf:

State-level lung cancer screening rates not aligned with lung cancer burden in the US
A new study reports that state-level lung cancer screening rates were not aligned with lung cancer burden.

The lung microbiome may affect lung cancer pathogenesis and prognosis
Enrichment of the lungs with oral commensal microbes was associated with advanced stage disease, worse prognosis, and tumor progression in patients with lung cancer, according to results from a study published in Cancer Discovery, a journal of the American Association for Cancer Research.

New analysis finds lung cancer screening reduces rates of lung cancer-specific death
Low-dose CT screening methods may prevent one death per 250 at-risk adults screened, according to a meta-analysis of eight randomized controlled clinical trials of lung cancer screening.

'Social smokers' face disproportionate risk of death from lung disease and lung cancer
'Social smokers' are more than twice as likely to die of lung disease and more than eight times as likely to die of lung cancer than non-smokers, according to research presented at the European Respiratory Society International Congress.

Lung cancer therapy may improve outcomes of metastatic brain cancer
A medication commonly used to treat non-small cell lung cancer that has spread, or metastasized, may have benefits for patients with metastatic brain cancers, suggests a new review and analysis led by researchers at St.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Lung transplant patients face elevated lung cancer risk
In an American Journal of Transplantation study, lung cancer risk was increased after lung transplantation, especially in the native (non-transplanted) lung of single lung transplant recipients.

Proposed cancer treatment may boost lung cancer stem cells, study warns
Epigenetic therapies -- targeting enzymes that alter what genes are turned on or off in a cell -- are of growing interest in the cancer field as a way of making a cancer less aggressive or less malignant.

Are you at risk for lung cancer?
This question isn't only for people who've smoked a lot.

Read More: Lung Cancer News and Lung Cancer Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to